PALEXIA sol 4 mg/ml fl 100 ml
7680628410035
CH-62841
N02AX06
01.01.3.
Active substances:
1 / 3
google
Details
- Product number
- 6284101
- CPT
- -
- Packaging group
- 100
- Unit
- ml
- Composition
- tapentadolum 4 mg ut tapentadoli hydrochloridum 4.66 mg, acidum citricum monohydricum, sucralosum, aromatica (Himbeere) cum propylenglycolum 1.88 mg, aqua purificata, natrii benzoas (E211) 2.36 mg, ad solutionem pro 1 ml corresp. natrium 0.378 mg.
Articles (1)
Palexia 4 mg/ml, Lösung zum Einnehmen
Lösung
100
Official Swissmedic V2 data
Additional information from the official database
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
tapentadolum
|
4.0 MG | Substance | Wirkstoff (Principe actif) |
|
tapentadoli hydrochloridum
|
4.66 MG | Substance | WIZUS |
|
acidum citricum monohydricum
|
- | Substance | HNIDK |
|
sucralosum
|
- | Substance | HNIDK |
|
aromatica
|
- | Substance | AROMA |
|
propylenglycolum
|
1.88 MG | Substance | HBESI |
|
aqua purificata
|
- | Substance | HNIDK |
|
natrii benzoas
|
2.36 MG | Substance | HBESI |
|
natrium
|
0.378 MG | Substance | HBESI |
Authorization holder
Grünenthal Pharma AG
None Glarus Süd
Authorization information
- Swissmedic authorization number
- 62841
- Drug name
- Palexia, Lösung zum Einnehmen
- Galenic form
- LSOR
- ATC Code
- N02AX06
- Authorization status
- Z
- Dispensation category
- A+
- First authorization
- 25/07/2013
- Authorization expiration date
- 31/12/9999
- IT number
- 01.01.3.
- Domain
- Human medicine
Packaging details
- Description (FR)
- PALEXIA sol 4 mg/ml fl 100 ml
- Description (DE)
- PALEXIA Lös 4 mg/ml Fl 100 ml
- Market launch
- 25/07/2013
- Narcotic (BTM)
- A